The evaluation and management of patients with neuroleptic malignant syndrome

Neurol Clin. 2004 May;22(2):389-411. doi: 10.1016/j.ncl.2003.12.006.

Abstract

NMS is a rare but fatal syndrome that needs to be considered in the perioperative period. Although many aspects remain unexplored and controversial, with greater awareness of the condition, new concepts are coming into light. Definitive treatment guidelines remain an important issue to be addressed. Efforts have been initiated in that direction and all cases can be reported on a toll-free hotline ( 1-888-667-8367) or online (www.nmsis.org).

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Catatonia / diagnosis
  • Diagnosis, Differential
  • Electroconvulsive Therapy / methods
  • Humans
  • Malignant Hyperthermia / diagnosis
  • Myocardial Infarction / chemically induced
  • Neuroleptic Malignant Syndrome / diagnosis*
  • Neuroleptic Malignant Syndrome / physiopathology
  • Neuroleptic Malignant Syndrome / therapy*
  • Serotonin Syndrome / diagnosis

Substances

  • Antipsychotic Agents